|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-7-15
|
|
pubmed:abstractText |
Defining the most appropriate treatment for patients with idiopathic membranous nephropathy is a matter of controversy. The course of the disorder is often benign, and the immunosuppressive regimens used in some patients have uncertain benefits and substantial risks. We studied the natural history of idiopathic membranous nephropathy in patients who received only symptomatic therapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
8
|
|
pubmed:volume |
329
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
85-9
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8510707-Adult,
pubmed-meshheading:8510707-Aged,
pubmed-meshheading:8510707-Creatinine,
pubmed-meshheading:8510707-Female,
pubmed-meshheading:8510707-Follow-Up Studies,
pubmed-meshheading:8510707-Glomerulonephritis, Membranous,
pubmed-meshheading:8510707-Humans,
pubmed-meshheading:8510707-Kidney Failure, Chronic,
pubmed-meshheading:8510707-Male,
pubmed-meshheading:8510707-Middle Aged,
pubmed-meshheading:8510707-Prognosis,
pubmed-meshheading:8510707-Proportional Hazards Models,
pubmed-meshheading:8510707-Prospective Studies,
pubmed-meshheading:8510707-Proteinuria,
pubmed-meshheading:8510707-Remission, Spontaneous,
pubmed-meshheading:8510707-Survival Analysis
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Prognosis of untreated patients with idiopathic membranous nephropathy.
|
|
pubmed:affiliation |
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
|
|
pubmed:publicationType |
Journal Article
|
